Aplastic anemia (AA) and myelodysplastic syndromes (MDS) are a heterogeneous group of rare hematological disorders belonging to the Bone Marrow Failure (BMF) syndromes. The Aplastic Anemia and Myelodysplastic Syndromes International Foundation (AA&MDSIF) is a non-profit organization dedicated to supporting patients and families living with a BMF disease. They work to bring investigators together in a collaborative manner. This article summarizes key presentations from the last AA&MDSIF scientific symposium held in Bethesda, Maryland on March 2010
The myelodysplastic syndromes (MDS) are charac-terized by hemopoietic insufficiency associated with ...
Myelodysplastic syndromes (MDS) constitute a heteroge-neous group of bone marrow disorders, which ar...
This book deals with the rapid progress in the area of myelodysplastic syndromes (MDS). MDS are a gr...
Aplastic anemia (AA) and myelodysplastic syndromes (MDS) are a heterogeneous group of rare hematolog...
Aplastic anemia (AA) is a rare and life-threatening hetero-geneous bone marrow (BM) failure disorder...
Bone marrow failure (BMF) syndromes are a heterogeneous group of benign hematological conditions cha...
The bone marrow failure states, aplastic anemia and myelodysplastic syndrome, are characterized by r...
This review highlights some of the contributions that have appeared in the literature in the past de...
Myelodysplastic syndromes (MDS), first clearlydefined as an entity by the pioneering studiesof Berna...
In the last 30 years, the field of aplastic anemia (AA), and more generally bone marrow failure synd...
In recent years, it has become increasingly apparent that bone marrow (BM) failures and myeloid mali...
In recent years, it has become increasingly apparent that bone marrow (BM) failures and myeloid mali...
Aplastic anemia (AA) is characterized by bone marrow (BM) hypocellularity, resulting in peripheral c...
This issue of eMedRef provides information to clinicians on the pathophysiology, diagnosis, and ther...
Myelodysplastic syndromes (MDS) are a collection of pathologi-cally and cytogenetically distinct bon...
The myelodysplastic syndromes (MDS) are charac-terized by hemopoietic insufficiency associated with ...
Myelodysplastic syndromes (MDS) constitute a heteroge-neous group of bone marrow disorders, which ar...
This book deals with the rapid progress in the area of myelodysplastic syndromes (MDS). MDS are a gr...
Aplastic anemia (AA) and myelodysplastic syndromes (MDS) are a heterogeneous group of rare hematolog...
Aplastic anemia (AA) is a rare and life-threatening hetero-geneous bone marrow (BM) failure disorder...
Bone marrow failure (BMF) syndromes are a heterogeneous group of benign hematological conditions cha...
The bone marrow failure states, aplastic anemia and myelodysplastic syndrome, are characterized by r...
This review highlights some of the contributions that have appeared in the literature in the past de...
Myelodysplastic syndromes (MDS), first clearlydefined as an entity by the pioneering studiesof Berna...
In the last 30 years, the field of aplastic anemia (AA), and more generally bone marrow failure synd...
In recent years, it has become increasingly apparent that bone marrow (BM) failures and myeloid mali...
In recent years, it has become increasingly apparent that bone marrow (BM) failures and myeloid mali...
Aplastic anemia (AA) is characterized by bone marrow (BM) hypocellularity, resulting in peripheral c...
This issue of eMedRef provides information to clinicians on the pathophysiology, diagnosis, and ther...
Myelodysplastic syndromes (MDS) are a collection of pathologi-cally and cytogenetically distinct bon...
The myelodysplastic syndromes (MDS) are charac-terized by hemopoietic insufficiency associated with ...
Myelodysplastic syndromes (MDS) constitute a heteroge-neous group of bone marrow disorders, which ar...
This book deals with the rapid progress in the area of myelodysplastic syndromes (MDS). MDS are a gr...